Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease lung cancer
Phenotype C0080032|malignant pleural effusions
Sentences 9
PubMedID- 25339042 Prognostic values of vegf and endostatin with malignant pleural effusions in patients with lung cancer.
PubMedID- 26125099 Pleural effusion levels of dj-1 are increased in elderly lung cancer patients with malignant pleural effusions.
PubMedID- 25798278 Response to bevacizumab combination chemotherapy of malignant pleural effusions associated with non-squamous non-small-cell lung cancer.
PubMedID- 24072496 Interleukin 17 (il-17) has been found to be increased in some human cancers; however, the possible implication of il-17 in regulating antitumor responses in lung cancer patients with malignant pleural effusions (mpe) remains to be elucidated.
PubMedID- 20207133 A phase i clinical and pharmacokinetic study of paclitaxel liposome infused in non-small cell lung cancer patients with malignant pleural effusions.
PubMedID- 23533029 In addition, the chemokine receptor ccr6 [which binds to the chemokine cc ligand 20 (ccl20) that is present in many malignant pleural effusions of lung cancer patients] is highly expressed on th17 cells thus further facilitating their recruitment to sites of tumor growth and inflammation (acosta-rodriguez et al., 2007; annunziato et al., 2007, 2012).
PubMedID- 23243596 The first one (nct00690261; current status: recruiting) specifically aims at investigating impact of m1/m2 macrophage polarization on cancer progression and prognosis prediction among lung cancer patients with malignant pleural effusions.
PubMedID- 25621068 Mmp-9 mrna expression levels in lymphocytes tended to be higher in malignant pleural effusions of lung cancer when compared with healthy pleural effusions (17).
PubMedID- 23364973 Diagnostic value and prognostic significance of pleural c-reactive protein in lung cancer patients with malignant pleural effusions.

Page: 1